ArcturusRx is a global brand specializing in late-stage clinical messenger RNA (mRNA) medicines and vaccines. Their main focus is on developing and commercializing therapeutics for rare diseases and vaccines. With proprietary technologies and extensive partnerships, ArcturusRx is at the forefront of innovative RNA-based therapeutics.

Based in San Diego, CA, ArcturusRx boasts a multicultural team dedicated to making a positive impact in the COVID-19 pandemic. They have developed an exciting COVID-19 vaccine candidate called STARR™, designed to protect people worldwide, regardless of their geographic location. ArcturusRx's commitment to inclusivity is reflected in their diverse team, proficient in multiple languages, including Arabic, Chinese, English, Farsi, French, German, Hebrew, Hindi, Italian, Japanese, Korean, Portuguese, Spanish, and Vietnamese.

Their expertise in delivery and RNA-based therapeutics enables them to explore and develop cutting-edge solutions for various diseases. With a strong pipeline of therapeutic candidates and a track record of scientific excellence, ArcturusRx is dedicated to improving patients' lives through the power of messenger RNA